| | | | |
CUSIP No. 268150109 | | 13G | | Page 12 of 19 Pages |
Item 1(a). | Name of Issuer: |
Dynatrace, Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
1601 Trapelo Road, Suite 116
Waltham, MA 02451
Item 2(a). | Name of Person Filing: |
This statement is being jointly filed by each of the entities below pursuant to Rule 13d-1(k) promulgated by the Securities and Exchange Commission pursuant to Section 13 of the Act, all of whom together are referred to herein as the “Reporting Persons”:
(i) Thoma Bravo Fund X, L.P.
(ii) Thoma Bravo Fund X-A, L.P.
(iii) Thoma Bravo Special Opportunities Fund I, L.P.
(iv) Thoma Bravo Special Opportunities Fund I AIV, L.P.
(v) Thoma Bravo Fund XI, L.P.
(vi) Thoma Bravo Fund XI-A, L.P.
(vii) Thoma Bravo Executive Fund XI, L.P.
(viii) Thoma Bravo Partners X, L.P.
(ix) Thoma Bravo Partners XI, L.P.
(x) Thoma Bravo UGP, LLC
The Reporting Persons have entered into a Joint Filing Agreement, dated February 16, 2021, a copy of which is attached as Exhibit 99.1 to this Schedule 13G, pursuant to which the Reporting Persons agreed to file this Schedule 13G and any amendments thereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.
Item 2(b). | Address of Principal Business Office or, if none, Residence: |
The principal business address of each of the Reporting Persons is as follows:
c/o Thoma Bravo, L.P.
150 N. Riverside Plaza
Suite 2800
Chicago, IL 60606
See responses to Item 4 on each cover page.
Item 2(d). | Titles of Classes of Securities: |
Common stock, $0.001 par value per share (the “Common Stock”)